Treating Addiction as a Chronic Illness: Why it is Finally Possible. A. Thomas McLellan Treatment Research Institute

Size: px
Start display at page:

Download "Treating Addiction as a Chronic Illness: Why it is Finally Possible. A. Thomas McLellan Treatment Research Institute"

Transcription

1 Treating Addiction as a Chronic Illness: Why it is Finally Possible. A. Thomas McLellan Treatment Research Institute 9/29/2014 Treatment Research Research Institute, Institute,

2 The End Because of ACA (but also other forces): 1. We will have access to reimbursement for more and different types of care than ever Addiction Specialty Care referrals could triple 2. Specialty care will NOT be programmatic it will adopt the Chronic Care Model Patient, professional and payment pressures 3. Treatment Goal = self-managed disease control Recovery will be one method of disease control

3 Use Driven by access and availability Abuse Use despite negative consequences Addiction Uncontrolled use driven by use but usually mediated by genes 3

4 Addiction An acquired, genetically mediated, chronic illness like diabetes. Cardinal feature is loss of control over urges to use resulting from sustained (?) changes in brain structure and function. Addictions can be successfully managed but not yet cured. 4

5 Population Prevalence Very Serious Use In Treatment ~ 2,300,000 Addiction ~ 23,000,000 Harmful 40,000,000 Use Little/No Use Little or No Use

6 1 Historical and Modern Treatment Approaches

7 A Nice Simple Rehab Model Substance Abusing Patient Treatment NTOMS Sample of 250 Programs Non- Substance Abusing Patient

8 ASSUMPTIONS Some fixed amount or duration of treatment should resolve the problem Clinical efforts should be put toward correctly placing patients and getting them to complete treatment Evaluation of effectiveness should occur following completion Poor outcome means failure

9 How Do Treatments For Other Illnesses Work? Chronic Illness & Continuing Care

10 A Continuing Care Model Primary Care Specialty Care Primary Continuing Care

11 In Chronic Illnesses. 1 There is no Cure - the effects of treatment do not persist after care stops 2 Patients who are out of contact are at elevated risk for relapse: Retention is essential

12 In Chronic Illnesses. 3 Early, intensive stages prepare patients for less intensive care: ultimately Self-Management 4 - Evaluation is a clinical duty: Good function = continue care Poor function = change care

13 1 Effects on Research and Evaluation

14 Outcome In Hypertension Pre During During During Post Treatment Research Institute

15 Outcome In Addiction Pre During During During Post Treatment Research Institute

16 A Real World Example Two Similar Matching Studies With Very Different Results

17 Project MATCH RCT - 3 Research-Derived Therapies $27 Million Dollar NIAAA Study Different Mechanisms of Action Fixed Interventions All Patients Goal Achieve Lasting Abstinence Post Completion

18 Project Match Fixed Time - Fixed Content Rehab Oriented Treatment Type Post Treatment Evaluations MET CBT 45% 38% 27% 12-Step

19 ALLHAT The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Treatment Research I nstitute

20 ALLHAT $63 million 61 sites Three Groups Different drug actions, Different drug costs Diuretic -$0.10 / pill Calcium Channel Blocker -$1.50 /pill Ace Inhibitor -$4.00 /pill Goal I mprovement on Pre-Specified Criterion DURING TREATMENT

21 ALLHAT Pre-Specified Criteria Adjustment Oriented Start 27% Control DURING Treatment Evaluations Step 1 Step 2 Step 3 Diuretic CCB 42% 55% 64% ACE

22 1 A Bad Habit not an Illness Leads to a Special Approach

23 1 Fundamentals of the Affordable Care Act Without all the Political Crap

24 2010 Healthcare Reform The Affordable Care Act Premises about healthcare: It is a right not a privilege It is a government responsibility Universal health insurance will reduce healthcare costs We will see? Inappropriate, expensive utilization Promote individual responsibility

25 2010 Healthcare Reform The Affordable Care Act Major Elements (Contd.): Health Insurance Expansion 22m Required Participation (payment) Medicaid the major mechanism Focus on Accountability Restore Primary Care PCMH Focus on Prevention Focus on Essential Benefits

26 2009 Parity Act MHPAEA If a health plan covers MH/SA benefits should be comparable to those of similar physical illnesses - Requires Insurer transparency 2010 ACA MH/SA coverage is mandatory - Essential Services

27 Why are SA Benefits Essential Very Serious Use In Treatment ~ 2,300,000 Addiction ~ 23,000,000 Little/No Use $120B/yr Harmful 40,000,000 Use Little or No Use

28 1 Implications for Substance Use Disorders

29 ACA Will Transform SA SA care is Essential Service SA is firmly part of healthcare Funds full continuum of care Prevent, BI, Meds, Spec Care Benefits will change The nature of benefits The payment mechanisms More/different providers

30 SUD Benefits Today Very Serious Use Addiction In Treatment ~ 2,300,000 Addiction ~ 23,000,000 Harmful 40,000,000 Use Little/No Use Little or No Use

31 Detoxification 100% Ambulatory 80% Opioid Substitution Therapy 50% Urine Drug Screen 100% 7 per year Note Great variability state to state

32 1 Medicaid Diabetes benefit

33 Physician Visits 100% Clinic Visits 100% Home Health Visits 100% Glucose Tests, Monitors, Supplies 100% Insulin and 4 other Meds 100% HgA1C, eye, foot exams 4x/yr 100% Smoking Cessation 100% Personal Care Visits 100% Language Interpreter - Negotiated

34 Physician Visits 100% Screening, Brief Intervention, Assessment Evaluation and medication Tele monitoring Clinic Visits 100% Home Health Visits 100% Family Counseling Alcohol and Drug Testing 100% 4 Maintenance and Anti-Craving Meds 100% Monitoring Tests (urine, saliva, other) Smoking Cessation 100%

35 Care of Substance Use Disorders Very Frequent Use Specialty/Chronic Care Disease Spectrum in Population to be Treated & Managed Office-Based Primary Care Prevention & Early Intervention Very Rare Use

36 Elements of a Chronic Care Model 1. Continually Measurable goal Disease Control = reduced symptoms, improved function, low costs Simple, accurate measurement during care 2. Diagnostic/Functional Assessment To produce an individualized treatment plan 3. Potent, Varied Therapeutic Components Medications, therapies, social services 4. Ability to Adjust Care According to Results

37 Tobacco (NRT, Varenicline, Vaccine) Alcohol (Naltrexone, Accamprosate, Disulfiram) Opiates (Naltrex., Methadone, Buprenorphine) Cocaine (Disulfiram, Topiramate, Vaccine) Marijuana Nothing Yet Methamphetamine Nothing Yet

38 Cognitive Behavioral Therapy Motivational Enhancement Therapy Community Reinforcement and Family Training Behavioral Couples Therapy Multi Systemic Family Therapy 12-Step Facilitation Individual Drug Counseling

39 Wait a Minute Yes We Do! 1. Continually Measurable goal Disease Control could equal negative urines & simple functional measures during care 2. Diagnostic/Functional Assessment Several available ASI, GAIN, ASAM 3. Potent, Varied Therapeutic Components Medications, therapies, social services 4. Abililty to Adjust Care According to Results Oh yeah we have programs that s how we have always been paid!

40 SPECTRUM OF ILLNESS & CONTINUUM OF CARE: Type 2 Diabetes Substance Use Disorders What is Needed? Pre- Diabetes Screening those at risk Motivational education Behavioral Interventions Electronic Monitoring Clinically Managed Diabetes Behavioral Interventions Medications Family/Peer Support Close Monitoring Personally Managed Diabetes Electronic Monitoring Social/Environment Services Family/Peer Supports

41 Chronic Care Model for Addiction 1. Stabilization If Needed 2. Clinical Management Setting(s), Components & Duration determined by: Patient Registry Data to start, then Concurrent Recovery Monitoring Results 3. Patient Self-Management

42 The End Because of ACA (but also other forces): 1. We will have access to reimbursement for more and different types of care than ever Addiction Specialty Care referrals could triple 2. Specialty care will NOT be programmatic it will adopt the Chronic Care Model Patient, professional and payment pressures 3. Treatment Goal = self-managed disease control Recovery will be one method of disease control

43

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication

More information

Healthcare Reform, and Substance Use Disorder (SUD) Treatment

Healthcare Reform, and Substance Use Disorder (SUD) Treatment Healthcare Reform, and Substance Use Disorder (SUD) Treatment Deni Carise, Ph.D Deputy Chief Clinical Officer, CRC Health Adjunct Clinical Professor, University of Pennsylvania, School of Medicine Disclosures

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences. Facing Addiction: Surgeon General s Report on Reducing Misuse and Addiction A.Thomas McLellan Senior Editor Key Terms Use Any use of any substance. Driven by market forces Misuse Use that can harm self

More information

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals.

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals. NIDA Principles of Treatment Peter Banys, M.D., M.Sc. CSAM Addiction Medicine Review Course San Francisco October 5 th, 2006 NIDA Principles of Treatment 1. Treatment Matching 2. Availability 3. Domains

More information

RI Centers of Excellence for the

RI Centers of Excellence for the RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic

More information

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the

More information

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in

More information

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality

More information

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

CTN Research Update. National Advisory Council on Drug Abuse May 8, Betty Tai, Ph.D. Center for the Clinical Trials Network

CTN Research Update. National Advisory Council on Drug Abuse May 8, Betty Tai, Ph.D. Center for the Clinical Trials Network CTN Research Update National Advisory Council on Drug Abuse May 8, 2013 Betty Tai, Ph.D. Center for the Clinical Trials Network CTN Steering Committee NIDA - CCTN NIDA National Drug Abuse Treatment Clinical

More information

Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care

Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care New Futures mission is to advocate, educate, and collaborate to reduce alcohol and other drug problems in New Hampshire. Expanding

More information

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over

More information

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

August 30, Washington, DC Washington, DC Dear Chairman Cochran, Chairman Blunt, Vice Chairman Leahy and Ranking Member Murray:

August 30, Washington, DC Washington, DC Dear Chairman Cochran, Chairman Blunt, Vice Chairman Leahy and Ranking Member Murray: August 30, 2017 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Washington, DC 20510 Washington, DC 20510 The Honorable Roy Blunt The Honorable Patty Murray Chairman Ranking

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

BASIC VOLUME. Elements of Drug Dependence Treatment

BASIC VOLUME. Elements of Drug Dependence Treatment BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Evidence-Based Practice: Psychosocial Interventions

Evidence-Based Practice: Psychosocial Interventions Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?

More information

Addiction Medicine: What s new for primary care

Addiction Medicine: What s new for primary care Addiction Medicine: What s new for primary care Dan Vinson, MD Family and Community Medicine How to talk so our patients listen, and listen so our patients talk. 1 2 Comfortably engaging your patient in

More information

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for

More information

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Management Options for Opioid Dependence:

Management Options for Opioid Dependence: Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services

More information

Fighting Today s Opioid Epidemic

Fighting Today s Opioid Epidemic Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,

More information

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Hot Topics in Addiction Medicine Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Financial Disclosures Speaker Bureau Indivior Research Support Constellation Health Onward Hot Topics

More information

The Sinclair Method (TSM) for the Treatment of Alcoholism. Clinical Research Findings and Best Protocol for Success Updated 2014

The Sinclair Method (TSM) for the Treatment of Alcoholism. Clinical Research Findings and Best Protocol for Success Updated 2014 Information for Medical & Treatment Professionals The Sinclair Method (TSM) for the Treatment of Alcoholism Clinical Research Findings and Best Protocol for Success Updated 2014 "One medication, naltrexone,

More information

Health Systems and Addiction: Provider Issues

Health Systems and Addiction: Provider Issues Health Systems and Addiction: Provider Issues The Emerging Roles of Primary Care Patrick G. O Connor MD, MPH Dan and Amanda Adams Professor of General Medicine Chief, General Internal Medicine Yale University

More information

Substance Abuse. Heather Gotham, PhD, Licensed Clinical Psychologist September 9, TB Nurse Case Management September 7-9, 2016 San Antonio, TX

Substance Abuse. Heather Gotham, PhD, Licensed Clinical Psychologist September 9, TB Nurse Case Management September 7-9, 2016 San Antonio, TX Substance Abuse Heather Gotham, PhD, Licensed Clinical Psychologist September 9, 2016 TB Nurse Case Management September 7-9, 2016 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Heather Gotham, PhD, Licensed

More information

Preparing for New Hampshire Behavioral Health Summit December 3, 2015

Preparing for New Hampshire Behavioral Health Summit December 3, 2015 Preparing for 2016 New Hampshire Behavioral Health Summit December 3, 2015 9.3 million more Americans have insurance Uninsured rate down to 11.9% Health spending historically low growth rate 3.7% 27

More information

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,

More information

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine [Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com

More information

Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders

Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders University of Kentucky From the SelectedWorks of Chizimuzo T.C. Okoli December, 2010 Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders Chizimuzo T.C.

More information

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC Robert L. DuPont, M.D. President, Institute for Behavior and Health, Inc. 2 nd Annual Symposium on Addiction

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit AODA RECOVERY How to support those in recovery, and those not yet ready to commit YOUR PRESENTER TODAY Robin Lickel is a psychotherapist and addictions specialist at Journey Mental Health Center in Madison,

More information

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE

More information

National Survey of Substance Abuse Treatment Services (N-SSATS)

National Survey of Substance Abuse Treatment Services (N-SSATS) U.S. Department of Health and Human Services FORM APPROVED: OMB No. 0930-0106 APPROVAL EXPIRES: 01/31/2016 See OMB burden statement on last page National Survey of Substance Abuse Treatment Services (N-SSATS)

More information

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics

More information

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of

More information

8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy

8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days

More information

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O. Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of

More information

Objectives 11/2/2016. Managing Patients with Substance Abuse. Off Label Disclosure. Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA

Objectives 11/2/2016. Managing Patients with Substance Abuse. Off Label Disclosure. Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA Managing Patients with Substance Abuse Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA Objectives Epidemiology: Substances most likely to be misused in HIV care settings. Diagnostic and

More information

MARRCH Minnesota Society of Addiction Medicine Presents. Addiction as a Brain Disease

MARRCH Minnesota Society of Addiction Medicine Presents. Addiction as a Brain Disease MARRCH 2008 Minnesota Society of Addiction Medicine Presents Addiction as a Brain Disease Gavin Bart, MD Charles Reznikoff, MD Steven Fu, MD, MSCE David Frenz, MD, MS October 22, 2008 Schedule 10:00-12:00

More information

Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations

Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations Dr. Ajeet Sidana Department of Psychiatry Government Medical College & Hospital Chandigarh Scope of Presentation

More information

Addiction and Recovery Treatment Services (ARTS) Reimbursement Structure

Addiction and Recovery Treatment Services (ARTS) Reimbursement Structure Page 1 of 13 Billing Code Service Name Service Description ASAM Level APPROVED CODES & RATES APPROVED BY CENTERS FOR MEDICARE AND MEDICAID SERVICES AUGUST 25, 2017 Community Based Care Unit Lengths Annual

More information

In 2008, an estimated 282,000 persons

In 2008, an estimated 282,000 persons National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Similarities and Differences in Opioid Treatment Programs that Provide Methadone Maintenance or Buprenorphine Maintenance

More information

The role of behavioral interventions in buprenorphine treatment of opioid use disorders

The role of behavioral interventions in buprenorphine treatment of opioid use disorders The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

Treating Tobacco Use Disorders as an Addiction: Why clinicians should address it, and some tools to help them. PAM BENNETT KATHY GARRETT

Treating Tobacco Use Disorders as an Addiction: Why clinicians should address it, and some tools to help them. PAM BENNETT KATHY GARRETT Treating Tobacco Use Disorders as an Addiction: Why clinicians should address it, and some tools to help them. PAM BENNETT KATHY GARRETT Objectives Why Tobacco Use should be viewed as an addiction Why

More information

Treating Opioid Addiction

Treating Opioid Addiction Treating Opioid Addiction Some people who start taking opioid pain medications eventually have serious problems with them and become addicted. Every day, 68 people die in the US from opioid overdose. More

More information

Treating Tobacco Use and Dependence

Treating Tobacco Use and Dependence Treating Tobacco Use and Dependence October 26, 2017 Great Plains Quality Improvement Network 1 Treating Tobacco Use and Dependence: Agenda Brief history and developmental process Facts about Tobacco Clinical

More information

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016 The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of

More information

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder Screening, Identification, Counseling, and Treatment of Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry, Harvard Medical School Director, Division of Addiction Psychiatry, Brigham

More information

How to Design a Tobacco Cessation Insurance Benefit

How to Design a Tobacco Cessation Insurance Benefit How to Design a Tobacco Cessation Insurance Benefit All tobacco users need access to a comprehensive tobacco cessation benefit to help them quit. A comprehensive tobacco cessation benefit includes: Nicotine

More information

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach Executive Summary Opioid use disorder: Supporting recovery with a medication-assisted treatment approach Opioid overprescription: Cause and effect The United States is currently facing an opioid-use crisis.

More information

Professional Assistance Program-NJ Presents: Healthcare Professional Impairment

Professional Assistance Program-NJ Presents: Healthcare Professional Impairment Professional Assistance Program-NJ Presents: Healthcare Professional Impairment Louis E. Baxter, Sr., M.D., DFASAM Executive Medical Director PAPNJ Past President - American Society Addiction Medicine

More information

The Social Worker s Role in Medication Assisted Treatment

The Social Worker s Role in Medication Assisted Treatment The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table

More information

Mass General s Substance Use Disorder Initiative

Mass General s Substance Use Disorder Initiative Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative None Disclosures Objectives

More information

Latest Research on Addiction and Treatment

Latest Research on Addiction and Treatment Latest Research on Addiction and Treatment Joshua D Lee MD MSc joshua.lee@nyumc.org / @DrJoshuaDLee Associate Professor NYU School of Medicine, Department of Population Health Disclosures, LeeJD Grants:

More information

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers Marwan S. Haddad, M.D. Community Health Center, Inc. Connecticut September 16, 2008 Community Health Center, Inc.

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

Methadone Maintenance 101

Methadone Maintenance 101 Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

Division of Mental Health and Addiction Services

Division of Mental Health and Addiction Services Division of Mental Health and Addiction Services A DAM BUCON, LSW DMHAS Mission DMHAS, in partnership with consumers, family members, providers and other stakeholders, promotes wellness and recovery for

More information

NIDA Quick Screen V1.0F1

NIDA Quick Screen V1.0F1 NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few

More information

Treating Addiction as a Chronic Disease

Treating Addiction as a Chronic Disease Treating Addiction as a Chronic Disease Sarah E. Wakeman, MD, FASAM Medical Director, MGH Substance Use Disorder Initiative Assistant Professor of Medicine, Harvard Medical School Disclosures Neither I

More information

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) Case 105- Prep Materials University of Massachusetts Medical School Opioid Conscious Curriculum Learner Prep Objectives The purpose of this prep material

More information

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society HOUSE Calls Published by the Alachua County Medical Society Winter 2017 Addiction Medicine Addiction as a Disease Gregory L. Jones, MD, FASAM, FAAF, UF Health Florida Recovery Center Scott A. Teitelbaum,

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

William H. Swiggart, MS

William H. Swiggart, MS William H. Swiggart, MS Co-Director, Center for Professional Health Vanderbilt University Medical Center 2015 All rights reserved. I have no financial relationships to disclose. The purpose of this session

More information

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :

More information

Best Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011

Best Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 Evidence-based and Innovative Treatment Models: Setting the Stage for our Discussions Best Practice Workgroup Considerations

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Buprenorphine Implant for Treatment of Opioid Dependence File Name: Origination: Last CAP Review: Next CAP Review: Last Review: buprenorphine_implant_for_treatment_of_opioid_dependence

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

SBIRT in Mental Health Settings

SBIRT in Mental Health Settings SBIRT in Mental Health Settings Teresa Halliday, MA Director, Practice Improvement Pam Pietruszewski, MA Integrated Health Consultant Overview 1. Rationale for support 2. Continuum of use and risk 3. Overview

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

WHAT IS HARM REDUCTION?

WHAT IS HARM REDUCTION? HARM REDUCTION WHAT IS HARM REDUCTION? Harm reduction is defined as, an umbrella term for interventions aiming to reduce the problematic effects of behaviors. Originally and frequently associated with

More information

Improving Diabetes Care A Roadmap to Better Chronic Care

Improving Diabetes Care A Roadmap to Better Chronic Care Improving Diabetes Care A Roadmap to Better Chronic Care Robert A. Gabbay, MD, PhD, FACP Chief Medical Officer Joslin Diabetes Center Harvard Medical School TODAY Diabetes as a Target Disease Patient Centered

More information

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN 1 ADDICTION PREVENTION & TREATMENT SAVES LIVES According to the Food and Drug Administration s standards for

More information

Stigma, Myths, Realities Limit Access to Care

Stigma, Myths, Realities Limit Access to Care Stigma, Myths, Realities Limit Access to Care MARGARET RUKSTALIS, MD Director ACGME Addiction Medicine Fellowship @ Wake Forest School of Medicine No personal or family conflicts of interest or history

More information

Serious Mental Illness and Opioid Use Disorder

Serious Mental Illness and Opioid Use Disorder Serious Mental Illness and Opioid Use Disorder Serious Mental Illness and Opioid Use Disorders Arthur Robin Williams, MD MBE Columbia University, Department of Psychiatry Nick Szubiak, MSW, LCSW Director,

More information

Tobacco dependence: Implications for service provision

Tobacco dependence: Implications for service provision Tobacco dependence: Implications for service provision Andy McEwen, PhD University College London & National Centre for Smoking Cessation and Training (NCSCT) Tuesday 29th January 2013 Cardiff Conflict

More information